H.I.G. Capital Acquires Aspire Pharma Limited

September 24, 2021

An affiliate of H.I.G. Capital has acquired Aspire Pharma Limited, a UK-based developer and licensor of niche generic and branded specialty pharmaceuticals. Founder Graham Fraser-Pye remains with the business as chairman; financial terms were not disclosed and H.I.G. said it will support Aspire's organic growth, M&A activity and international expansion.

Buyers
H.I.G. Capital
Targets
Aspire Pharma Limited
Industry
Pharmaceuticals
Location
Hampshire, United Kingdom
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.